Andreas Benneche

Further delineation of the clinical spectrum of White–Sutton syndrome: 12 new individuals and a review of the literature

K. Prescott, A. Fry, S. Berland, 2021, European Journal of Human Genetics.

A Nationwide Study of GATA2 Deficiency in Norway—the Majority of Patients Have Undergone Allo-HSCT

B. Fevang, A. Stray-Pedersen, E. Galteland, 2021, Journal of Clinical Immunology.

Gain-of-function mutations in ALPK1 cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome

Alexander H. Yang, D. Kastner, H. Takada, 2022, Annals of the Rheumatic Diseases.

Validation and clinical application of transactivation assays for RUNX1 variant classification

T. Illig, T. Tvedt, A. Agarwal, 2022, Blood advances.

Screening patients with autoimmune endocrine disorders for cytokine autoantibodies reveals monogenic immune deficiencies.

E. C. Røyrvik, P. Knappskog, E. Husebye, 2022, Journal of autoimmunity.

Further delineation of the clinical spectrum of White–Sutton syndrome: 12 new individuals and a review of the literature

A. Fry, S. Berland, J. Carmichael, 2021, European Journal of Human Genetics.

Bi‐allelic KARS1 pathogenic variants affecting functions of cytosolic and mitochondrial isoforms are associated with a progressive and multisystem disease

E. Bertini, A. Vanderver, N. Brunetti‐Pierri, 2021, Human mutation.

A Nationwide Study of GATA2 Deficiency in Norway—the Majority of Patients Have Undergone Allo-HSCT

B. Fevang, A. Stray-Pedersen, E. Galteland, 2021, Journal of clinical immunology.

Hyperferritinemi-katarakt-syndrom

H. Reikvam, Å. Bakke, Andreas Benneche, 2020, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

VEXAS Syndrome in a Patient with Myeloproliferative Neoplasia

T. Madland, T. Haslerud, Andreas Benneche, 2023, Case reports in hematology.